Occipital neural dynamics in cannabis and alcohol use: independent effects of addiction.
- Authors
- Lew, Brandon J; Salimian, Anabel; Wilson, Tony W
- Year
- 2021
- Journal
- Scientific reports
- PMID
- 34782632
- DOI
- 10.1038/s41598-021-01493-y
- PMCID
- PMC8593162
Alcohol and cannabis use disorder (AUD/CUD) are two of the most common addictive disorders. While studies are beginning to understand the neural changes related to acute and chronic use, few studies have examined the independent effects of AUD and CUD on neural oscillatory activity. We examined 45 adults who reported current use of both cannabis and alcohol. Participants underwent the SCID-V to determine whether they met criteria for AUD and/or CUD. Participants also completed a visual-spatial processing task while undergoing magnetoencephalography (MEG). ANCOVA with a 2 × 2 design was then used to identify the main effects of AUD and CUD on source-level oscillatory activity. Of the 45 adults, 17 met criteria for AUD, and 26 met criteria for CUD. All participants, including comparison groups, reported use of both cannabis and alcohol. Statistical analyses showed a main effect of AUD, such that participants with AUD displayed a blunted occipital alpha (8-16 Hz) response. Post-hoc testing showed this decreased alpha response was related to increased AUD symptoms, above and beyond amount of use. No effects of AUD or CUD were identified in visual theta or gamma activity. In conclusion, AUD was associated with reduced alpha responses and scaled with increasing severity, independent of CUD. These findings indicate that alpha oscillatory activity may play an integral part in networks affected by alcohol addiction.
MEG sensor-level spectrograms and source images. (A) Sensor-level analysis revealed distinct oscillatory responses within the theta (4–8 Hz), alpha (8–16 Hz), and gamma (64–74 Hz) bands during visual processing in the occipital cortices. Each spectrogram reflects activity of a representative occipital MEG sensor that has been grand-averaged across all participants. The color scale legend shown on the right displays percent change from baseline (red indicating an increase in power relative to baseline and blue reflecting a decrease relative to baseline). (B) Significant sensor-level time–frequency components were imaged using a beamforming approach in each participant individually, and the resulting maps were grand-averaged across all participants per oscillatory response. The resulting functional maps reveal increases (i.e., synchronizations) in the theta and gamma range in the bilateral medial occipital cortices, as well as decreases in the strength (i.e., desynchronization) of alpha activity in more lateral occipital cortices. Color scale legends to the right of each image indicate average baseline-normalized power (pseudo-t) thresholds.
LLM interpretation
Figure A consists of two sensor-level spectrograms plotting frequency (Hz) against time (ms), showing percent change from baseline for occipital theta/alpha (5–30 Hz) and gamma (60–80 Hz) bands. The theta/alpha plot shows a power increase (red) around 5–10 Hz and a power decrease (blue) around 10–15 Hz, while the gamma plot shows a power increase (red) between 64–74 Hz. Figure B displays three grand-averaged source images on brain slices, showing power increases in the bilateral medial occipital cortices for theta and gamma, and a power decrease in the lateral occipital cortices for alpha.
Voxel time series of alpha activity during visual-spatial processing. Grand averaged alpha source images revealed peak voxels in bilateral visual cortices. Time series were then extracted from these voxels in each participant, averaged across hemisphere, and were plotted with time (ms) on the x-axis and relative amplitude (%) on the y-axis. For display purposes, the time series has been averaged across those with AUD (teal) and those without AUD (purple). The area highlighted in gray (300 to 550 ms) reflects the time period that was used for the source analysis. Factorial ANCOVA showed a main effect of AUD, such that individuals diagnosed with AUD (teal) exhibited a significantly weaker alpha response compared to those without AUD (purple). Error bars indicate \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\pm 1$$\end{document}±1 standard error of the mean. To the right, source images of the alpha response have been split according to AUD diagnosis with the color scale legend shown on the right. These images clearly show the same effect observed in the time series data. Note that these images are shown for display purposes only and statistical comparisons were made using the average over the highlighted active window from the extracted time series in an ANCOVA model.
LLM interpretation
This figure consists of a time-series line plot and two corresponding brain source images showing alpha activity during visual-spatial processing. The line plot displays relative power (%) over time (ms), showing that the "With AUD" group (teal) maintains a higher relative amplitude compared to the "No AUD" group (purple), particularly within the gray-highlighted window (300–550 ms). The accompanying source images use a pseudo-t color scale to visualize the alpha response, with the "No AUD" group showing a larger, more intense area of activation in the visual cortices than the "With AUD" group.
Spearman correlation between alpha power and number of AUD symptoms. Post-hoc testing of alpha power showed a significant correlation between number of AUD symptoms and alpha power such that participants that had more severe AUD exhibited weaker alpha responses. This relationship remained significant in a larger regression model that included number of CUD symptoms, and metrics of cannabis and alcohol consumption, showing that decreased alpha responses are associated with more severe AUD, above and beyond amount of alcohol consumption and cannabis consumption/use disorder. Note that more negative alpha power indicates a stronger alpha response (larger change from baseline). Shaded area represents 95% confidence interval.
LLM interpretation
This is a scatter plot with a linear regression line and a shaded 95% confidence interval showing the relationship between the number of AUD symptoms (x-axis) and alpha power as a percentage change from baseline (y-axis). The data shows a positive correlation ($R = 0.32, p = 0.034$), indicating that as the number of AUD symptoms increases, alpha power values become less negative. According to the legend, this trend represents a weaker alpha response associated with more severe AUD.
Visual-spatial processing task. Every trial began with a fixation period lasting 1900 to 2100 ms, which was then followed by the stimulus grid (duration = 800 ms). The stimulus grid was presented in one of four locations; off-center by 75% to either the right or the left of the fixation crosshair in the top or lower quadrant. Participants were instructed to use the response pad to indicate whether the grid was presented to the left (index finger) or right (middle finger).
LLM interpretation
This diagram illustrates the sequence of a visual-spatial processing task, moving from left to right. It shows a fixation period followed by the presentation of a checkerboard stimulus grid in one of four off-center locations (top-left, bottom-left, top-right, or bottom-right). The final stage depicts a response pad where participants use their index finger (button 1) for left stimuli or middle finger (button 2) for right stimuli, as highlighted by yellow boxes.
| Name | Type |
|---|---|
| 45 enrollees local | cohort |
| accuracy | phenotype |
| acute cannabis use local | phenotype |
| addiction | phenotype |
| Addiction-related aberrations local | phenotype |
| adolescents | cohort |
| Adults with AUD and/or CUD local | cohort |
| Adults without AUD and/or CUD local | cohort |
| age | phenotype |
| alcohol | phenotype |
| alcohol dependence | phenotype |
| Alcohol Use Disorder | phenotype |
| alpha activity | phenotype |
| alpha oscillations | phenotype |
| alpha oscillatory activity local | phenotype |
| Alpha oscillatory activity local | anatomy |
| Alpha Oscillatory Activity local | phenotype |
| Alpha oscillatory power local | phenotype |
| alpha power | phenotype |
| Alpha response local | phenotype |
| attentional processing local | phenotype |
| Attention processing local | phenotype |
| AUD | phenotype |
| AUDIT | phenotype |
| AUD participants | cohort |
| Baseline alpha activity local | anatomy |
| Basic visual processing local | phenotype |
| Beck depression total score local | phenotype |
| beta oscillations | phenotype |
| binge drinking | phenotype |
| Both AUD and CUD group local | cohort |
| cannabinoid-1 receptor (CB1R) local | drug |
| Cannabis and alcohol users local | cohort |
| cannabis dependence | phenotype |
| cannabis use | phenotype |
| cannabis use disorder | phenotype |
| cannabis users | phenotype |
| Cardiac Pacemaker local | drug |
| CNS-affecting Chronic Medical Illness local | phenotype |
| Compulsive substance use local | phenotype |
| Control group of substance users local | cohort |
| cortex | anatomy |
| CUD | phenotype |
| CUDIT-C local | phenotype |
| CUDIT total score local | phenotype |
| CUD symptoms | phenotype |
| drug dependence | phenotype |
| Dual-use adult cohort local | cohort |
| executive function | phenotype |
| Ferrous Metal Implant local | drug |
| Frequency-specific alterations local | phenotype |
| frontal cortex | anatomy |
| fronto-parietal network | anatomy |
| gamma activity | phenotype |
| gamma-aminobutyric acid (GABA) | drug |
| Gamma band activity local | phenotype |
| gamma oscillations | phenotype |
| gamma oscillatory activity local | phenotype |
| Gamma Oscillatory Activity local | phenotype |
| gamma response local | phenotype |
| glutamate | drug |
| heavy drinking | phenotype |
| Large-quantity substance consumption local | phenotype |
| Lateral occipital cortex | anatomy |
| marijuana | phenotype |
| marijuana use disorder | phenotype |
| medial occipital cortices local | anatomy |
| Minimal/no alcohol users local | cohort |
| Minimal to no alcohol use local | phenotype |
| misuse | phenotype |
| motor cortex | anatomy |
| National Comorbidity Survey | cohort |
| Non-Alcohol Use Disorder local | phenotype |
| Non-Cannabis Use Disorder local | phenotype |
| Non-use disorder comparison group local | cohort |
| Normal depression local | phenotype |
| No substance use disorder group local | cohort |
| Occipital alpha response local | anatomy |
| occipital cortex | anatomy |
| Only AUD group local | cohort |
| Only CUD group local | cohort |
| Orthodontures local | drug |
| oscillatory activity | phenotype |
| other substances | phenotype |
| other SUDs local | phenotype |
| participants | cohort |
| Population of alcohol and cannabis users local | cohort |
| pregnancy | phenotype |
| primary visual cortex | anatomy |
| primary visual cortices local | anatomy |
| psychotropic medication | drug |
| reaction time | phenotype |
| Reduced alpha response local | phenotype |
| Separate alcohol-cannabis use local | phenotype |
| sex | phenotype |
| Simultaneous alcohol-cannabis use local | phenotype |
| Study cohort (45 participants) local | cohort |
| substance use | phenotype |
| Surgical Implants local | drug |
| theta activity | phenotype |
| theta oscillations | phenotype |
| Theta Oscillatory Activity local | phenotype |
| theta response local | phenotype |
| tobacco use | phenotype |
| University of Nebraska Medical Center local | cohort |
| Use disorder severity local | phenotype |
| Use disorder symptoms local | phenotype |
| visual association areas local | anatomy |
| visual oscillatory activity local | phenotype |
| Visual oscillatory activity local | phenotype |
| Visual processing abilities local | phenotype |
| Visual-spatial processing local | phenotype |
| visual-spatial processing deficits local | phenotype |
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| RNA alternative splicing impacts the risk for alcohol use disorder. | 2023 | 37217680 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Chronic cannabis use differentially modulates neural oscillations serving the manipulate versus maintain components of working memory processing. | Huang PJ et al. | — | 2025 | → |
| Chronic Cannabis users exhibit altered oscillatory dynamics and functional connectivity serving visuospatial processing. | Castelblanco CA et al. | — | 2024 | → |
| Multispectral brain connectivity during visual attention distinguishes controlled from uncontrolled hypertension. | Son JJ et al. | — | 2024 | → |
| Altered functional connectivity and oscillatory dynamics in polysubstance and cannabis only users during visuospatial processing. | Weyrich L et al. | — | 2023 | → |
| RNA alternative splicing impacts the risk for alcohol use disorder | Liu Y et al. | — | 2023 | — |
| RNA alternative splicing impacts the risk for alcohol use disorder. | Li R et al. | — | 2023 | → |